Inhalation Drug Delivery Devices Market

Boston, MA

ReportsWorldwide has announced the addition of a new report title Inhalation Drug Delivery Devices Market to its growing collection of premium market research reports.

The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period.

Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines.

The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the inhalation drug delivery devices markets, including MDIs, DPIs, and nebulizers for the treatment of asthma and COPD.

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/inhalation-drug-delivery-devices-market

KEY QUESTIONS ANSWERED

• What are the key drivers and limiters to the inhalation drug delivery devices market?
• Which competitors are leading the market and introducing new technology?
• How are technological advancements impacting market growth?
• What factors are driving epidemiologic growth in the inhalation drug delivery devices market?

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=42265

INHALATION MARKET HIGHLIGHTS

• The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million.
• The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period.
• Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines.
• The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com

This release was published on openPR.